Literature DB >> 9248910

Axillary brachial plexus block--an underused technique in the accident and emergency department.

C A Mackay1, D F Bowden.   

Abstract

OBJECTIVE: To compare axillary brachial plexus block and Bier's block as methods of providing upper limb anaesthesia.
METHODS: Axillary brachial plexus or Bier's blocks were performed on all patients requiring upper limb anaesthesia in a three month period. For Bier's block, a single cuff tourniquet and 3 mg/kg 0.5% prilocaine were used. For axillary plexus block, 40 ml 1% lignocaine with adrenaline (1:200,000) were used, given by perivascular or transarterial technique. Prospective analysis was made of time to complete limb anaesthesia, type of procedure performed, and duration of limb anaesthesia. Patient perception of analgesia and satisfaction with the method of anaesthesia was assessed using a 10 point visual analogue scale.
RESULTS: 75 patients underwent procedures requiring upper limb anaesthesia; 39 received axillary plexus block and 36 Bier's block. 72% of Bier's blocks and 77% of axillary plexus provided complete anaesthesia without the need for supplemental analgesia. The median time to onset of anaesthesia was 10 min for Bier's block and 32.5 min for axillary block (P < 0.001). The median duration of anaesthesia was 15 min for Bier's block and 240 min for axillary block (P < 0.001). Mean scores for analgesia were 9.7 for axillary blocks and 8.8 for Bier's block (P < 0.001). 87% of the axillary block group were completely satisfied with the method of anaesthesia, compared with 56% of the Bier's block group.
CONCLUSIONS: Brachial plexus blocks are an alternative form of providing upper limb anaesthesia in the accident and emergency department. They are relatively simple to perform, well tolerated by patients, and have the advantage of providing prolonged analgesia without the need for additional medication.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9248910      PMCID: PMC1342946          DOI: 10.1136/emj.14.4.226

Source DB:  PubMed          Journal:  J Accid Emerg Med        ISSN: 1351-0622


  26 in total

1.  Infraclavicular brachial plexus block--a new approach.

Authors:  P P Raj; S J Montgomery; D Nettles; M T Jenkins
Journal:  Anesth Analg       Date:  1973 Nov-Dec       Impact factor: 5.108

2.  Interscalene brachial plexus block.

Authors:  A P Winnie
Journal:  Anesth Analg       Date:  1970 May-Jun       Impact factor: 5.108

3.  Perivascular axillary block IV: blockade following 40, 50 or 60 ml of mepivacaine 1% with adrenaline.

Authors:  T Vester-Andersen; B Husum; T Lindeburg; L Borrits; I Gøthgen
Journal:  Acta Anaesthesiol Scand       Date:  1984-02       Impact factor: 2.105

4.  Perivascular axillary block III: blockade following 40 ml of 0.5%, 1% or 1.5% mepivacaine with adrenaline.

Authors:  T Vester-Andersen; C Eriksen; C Christiansen
Journal:  Acta Anaesthesiol Scand       Date:  1984-02       Impact factor: 2.105

5.  Intravenous regional anaesthesia.

Authors:  J E Goold
Journal:  Br J Hosp Med       Date:  1985-06

6.  The extent of blockade following various techniques of brachial plexus block.

Authors:  E Lanz; D Theiss; D Jankovic
Journal:  Anesth Analg       Date:  1983-01       Impact factor: 5.108

7.  Functional anatomy of the brachial plexus sheaths.

Authors:  G E Thompson; D K Rorie
Journal:  Anesthesiology       Date:  1983-08       Impact factor: 7.892

8.  Comparison of bupivacaine hydrochloride and carbonated bupivacaine in brachial plexus blood by the interscalene technique.

Authors:  J H McClure; D B Scott
Journal:  Br J Anaesth       Date:  1981-05       Impact factor: 9.166

9.  Perivascular axillary block II: influence of injected volume of local anaesthetic on neural blockade.

Authors:  T Vester-Andersen; C Christiansen; M Sørensen; H O Kaalund-Jørgensen; P Saugbjerg; K Schultz-Møller
Journal:  Acta Anaesthesiol Scand       Date:  1983-04       Impact factor: 2.105

10.  Haematoma block--a safe method of reducing Colles' fractures.

Authors:  R D Case
Journal:  Injury       Date:  1985-07       Impact factor: 2.586

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.